Search results

  1. ABi001-A

    Russia Moscow Institute of Physics and Technology (National Research University) (AB)
    Disease:

    Cone dystrophy with supernormal rod response

  2. ABi002-A

    Russia Moscow Institute of Physics and Technology (National Research University) (AB)
    Disease:

    Cone dystrophy with supernormal rod response

  3. ABi004-A (KAA)

    Russia Moscow Institute of Physics and Technology (National Research University) (AB)
    Disease:

    Cone dystrophy with supernormal rod response

  4. AHMUi001-A

    China dongmei ji (AHMU)
    Disease:

    Leber hereditary optic neuropathy

  5. AHQUi001-A (IPS35-2)

    China Affiliated Hospital of Qingdao University (AHQU)
    Disease:

    Non rare in europe: hyperlipoproteinemia type 4

  6. AIBNi015-A (SPG1-AU01C15)

    Australia Australian Institute for Bioengineering and Nanotechnology (AIBN)
    Disease:

    Hereditary spastic paraplegia 56

  7. AIBNi016-A (SPG2-S376C1)

    Australia Australian Institute for Bioengineering and Nanotechnology (AIBN)
    Disease:

    Hereditary spastic paraplegia 56

  8. AIBNi017-A (SPGh1-S075mC2)

    Australia Australian Institute for Bioengineering and Nanotechnology (AIBN)
    Disease:

    Hereditary spastic paraplegia 56

  9. AIBNi018-A (SPGh2-S964pC6)

    Australia Australian Institute for Bioengineering and Nanotechnology (AIBN)
    Disease:

    Hereditary spastic paraplegia 56

  10. UCSFi001-A-1 (AICS-0005-050)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  11. UCSFi001-A-3 (AICS-0016-184)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  12. UCSFi001-A-4 (AICS-0075-085)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  13. UCSFi001-A-5 (AICS-0011-027)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  14. UCSFi001-A-6 (AICS-0013-210)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  15. UCSFi001-A-7 (AICS-0017-065)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  16. UCSFi001-A-8 (AICS-0010-055)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  17. UCSFi001-A-9 (AICS-0014-006)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  18. UCSFi001-A-10 (AICS-0023-020)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  19. UCSFi001-A-11 (AICS-0024-080)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  20. UCSFi001-A-12 (AICS-0036-006)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  21. UCSFi001-A-13 (AICS-0022-037)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  22. UCSFi001-A-14 (AICS-0025-001)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  23. UCSFi001-A-15 (AICS-0025-044)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  24. UCSFi001-A-16 (AICS-0031-035)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  25. UCSFi001-A-17 (AICS-0032-019)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  26. UCSFi001-A-18 (AICS-0030-022)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  27. UCSFi001-A-19 (AICS-0033-115)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  28. UCSFi001-A-20 (AICS-0040-013)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  29. UCSFi001-A-21 (AICS-0040-035)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  30. UCSFi001-A-22 (AICS-0053-016)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  31. UCSFi001-A-23 (AICS-0054-091)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  32. UCSFi001-A-24 (AICS-0057-050)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  33. UCSFi001-A-25 (AICS-0058-067)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  34. UCSFi001-A-26 (AICS-0037-172)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  35. UCSFi001-A-27 (AICS-0048-039)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  36. UCSFi001-A-28 (AICS-0061-036)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  37. UCSFi001-A-29 (AICS-0052-003)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  38. UCSFi001-A-30 (AICS-0046-051)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  39. UCSFi001-A-31 (AICS-0069-088)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  40. UCSFi001-A-33 (AICS-0059-036)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  41. UCSFi001-A-34 (AICS-0068-009)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  42. UCSFi001-A-35 (AICS-0080-069)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  43. UCSFi001-A-36 (AICS-0036-028)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  44. UCSFi001-A-37 (AICS-0074-026)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  45. UCSFi001-A-38 (AICS-0084-018)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  46. UCSFi001-A-39 (AICS-089-061)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  47. UCSFi001-A-40 (AICS-094-024)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  48. UCSFi001-A-41 (AICS-0034-062)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  49. UCSFi001-A-42 (AICS-0086-147)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  50. UCSFi001-A-43 (AICS-0087-031)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  51. UCSFi001-A-44 (AICS-0063-096)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  52. UCSFi001-A-45 (AICS-0090-391)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  53. UCSFi001-A-46 (AICS-0095-018)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  54. UCSFi001-A-47 (AICS-0096-074)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  55. UCSFi001-A-63 (AICS-0082-001)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  56. UCSFi001-A-66 (AICS-0114-032)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  57. UCSFi001-A-67 (AICS-0114-035)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  58. UCSFi001-A-69 (AICS-0083-005)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  59. UCSFi001-A-70 (AICS-0083-124)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal (average)

  60. AMUFAHi002-A (AY20210813)

    China The First Affiliated Hospital of Anhui Medical University (AMUFAH)
    Disease:

    Polycystic ovary syndrome

  61. AMUFAHi003-A

    China The First Affiliated Hospital of Anhui Medical University (AMUFAH)
    Disease:

    Normal (average)

  62. WAe009-A-1F (TSC2-/-)

    China Anzhen Hospital (ANZH)
    Disease:

    Tuberous sclerosis 2

  63. WAe009-A-89

    China Anzhen Hospital (ANZHEN)
    Disease:

    Sorsby fundus dystrophy

  64. ATCi002-A

    China Aegicare (Shenzhen) Technology Co (ATC)
    Disease:

    Keipert syndrome

  65. WAe009-A-1E (TBX20-KO)

    China Anzhen Hospital (ANZHEN) (AZH)
    Disease:

    Dilated cardiomyopathy

  66. WAe009-A-1H (MYL3-KO)

    China Anzhen Hospital (ANZHEN) (AZH)
    Disease:

    Hypertrophic cardiomyopathy

  67. BBANTWi008-A (iPSC_PBMC_LDS_SMAD3_T1_C11)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Loeys-dietz syndrome 3

  68. BBANTWi009-A

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Meester-loeys syndrome

  69. BBANTWi010-A (iPSC_PBMC_LDS_TGFB3_KE2M_C9)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Loeys-dietz syndrome 5

  70. BBANTWi011-A

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Familial thoracic aortic aneurysm and aortic dissection

  71. BCHNi001-A (BCHi001-A)

    China Beijing Children′s Hospital:Department of Nephrology (BCHN)
    Disease:

    Bardet-biedl syndrome

  72. BCHNCi001-A

    China Beijing Children's Hospital, Center of Neurology (BCHNC)
    Disease:

    Early infantile epileptic encephalopathy

  73. BCHNCi003-A

    China Beijing Children's Hospital, Center of Neurology (BCHNC)
    Disease:

    Mitochondrial pyruvate carrier deficiency

  74. BCHNDi001-A

    China 徐超龙 (BCHND)
    Disease:

    Mitochondrial encephalomyopathy

  75. BCRTi006-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Focal segmental glomerulosclerosis

  76. BIHi001-A-1 (iBCRT Cas9v1-3G-Kl.16)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (average)

  77. BIHi004-A (NHDF Epi5 Cl5 iPSC)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (average)

  78. BIHi005-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal (average)

  79. BIHi009-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  80. BIHi010-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  81. BIHi015-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  82. BIHi016-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  83. BIHi017-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  84. BIHi018-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  85. BIHi024-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  86. BIHi025-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  87. BIOi002-A

    China Beijing Institute of Ophthalmology (BIO)
    Disease:

    Autosomal dominant optic atrophy

  88. BIOi003-A (LYN-C1-P6)

    China Beijing Institute of Ophthalmology (BIO)
    Disease:

    Hereditary retinal dystrophy

  89. SIGi001-A-15 (SIGi001-A Dox inducible NGN2)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  90. SIGi001-A-17 (SIGi001-A-9 Dox inducible NGN2)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  91. SIGi001-A-18 (SIGi001-A-12 Bi-Allelic MAPT HA-tag #U28-12-P29-5)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  92. SIGi001-A-19 (SIGi001-A-12 Dox inducible NGN2)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  93. RCi004-A-1 (RCi004-A + HTT GC #H34-32_T34-23)

    Denmark Bioneer (BION)
    Disease:

    Huntington disease

  94. BIONi010-B (K2P53 and BIONi010-B)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  95. BIONi010-C-41 (BIONi010-C + iNGN2 Two-plasmid system/CRISPR-2)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  96. BIONi010-C-42 (BIONi010-C + iCRE AAVS1)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  97. BIONi010-C-43 (BIONi010-C + aSNCA-wt AAVS1)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  98. BIONi010-C-44 (BIONi010-C + aSNCA-A53T AAVS1)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  99. BIONi010-C-45 (BIONi010-C iCRE AAVS1 GBA1 LoxP EX5-6)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  100. BIONi010-C-49 (BIONi010-C + synapsin-m2rtTA + SNCA-wt)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  101. BIONi010-C-50 (BIONi010-C + synapsin-m2rtTA + SNCA-A53T)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  102. BIONi010-C-52 (BIONi010-C with an APOE 2/2 genotype (with two functional alleles in contrast to BIONi010-C-6))

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  103. BIONi010-C-53 (BIONi010-C with an APOE 3/3 genotype (with two functional alleles in contrast to BIONi010-C-2))

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  104. BIONi010-C-54 (BIONi010-C with an APOE 4/4 genotype (with two functional alleles in contrast to BIONi010-C-4))

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  105. BIONi010-C-70 (BIONi010-C with an APOE 2/2 genotype with an additional, homozygous christchurch mutation)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  106. BIONi010-C-71 (BIONi010-C with an APOE 3/3 genotype with an additional, homozygous christchurch mutation)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  107. BIONi010-C-72

    Denmark Bioneer (BION)
    Disease:

    Alzheimer's disease

  108. BIONi014-A (H270715 47-1 and SAMEA4342566)

    Denmark Bioneer (BION)
    Disease:

    Normal (average)

  109. BJTTHi001-A

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Normal (average)

  110. BJTTHi001-A-3

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Epilepsy

  111. BJTTHi001-A-4

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Epilepsy

  112. BJTTHi001-A-5

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Epilepsy

  113. BRCi021-A (TUH1)

    Japan RIKEN BioResource Research Center (BRC)
    Disease:

    Cardiomyopathy

  114. CBCHi001-A-1

    China Beijing Chest Hospital (CBCH)
    Disease:

    Hypertrophic cardiomyopathy

  115. CBDTi001-A

    India Institute for Stem Cell Science and Regenerative Medicine (CBDT)
    Disease:

    Normal (average)

  116. CBIGi001-A (AIW002-02)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Normal (average)

  117. CBIGi001-A-1 (PRKN-KO and PRKN-KO/AIW002-02)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson disease

  118. CBIGi001-A-2 (PINK1-KO and PINK1-KO/AIW002-02)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson disease

  119. CBIGi001-A-3 (PINK1-KO/PRKN-KO/AIW002-02 and PINK1-KO/PRKN-KO)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson disease

  120. CBIGi002-A (2890 (GBA W378G, heterozygous) and 2890)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson disease

  121. CBIGi002-A-1 (GBA W378G-correction/2890 and 2890-iso)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson disease

  122. CBIGi003-A (3026 and 3026 (GBA N370S, heterozygous))

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson disease

  123. CBIGi003-A-1 (3026-iso and GBA N370S-correction/3026)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson disease

  124. CBRCULi001-A (13-6545-1)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Normal (average)

  125. CBRCULi002-A (19-1035-10)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Myotonic dystrophy type 1

  126. CBRCULi003-A (59-0944-2)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Myotonic dystrophy type 1

  127. CBRCULi004-A (79-1660-2)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Myotonic dystrophy type 1

  128. CBRCULi005-A (91-3158-1)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Myotonic dystrophy type 1

  129. CCMi007-A (SAS1 C5)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Covid-19 infection

  130. CCMi008-A (SAS2 C1)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Covid-19 infection

  131. CCMi009-A (SAS3 C10)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Covid-19 infection

  132. CCMi011-A (SAS7 C6)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Covid-19 infection

  133. WAe009-A-1D

    China Cancer Center,Union Hospital (CCUH)
    Disease:

    Long qt syndrome 1

  134. CDIi011-A (21527)

    United States FUJIFILM Cellular Dynamics, Inc. (CDI)
    Disease:

    Normal (average)

  135. CHCMUi001-A

    China Children's hospital of Chongqing Medical University (CHCMU)
    Disease:

    Activated pi3k-delta syndrome

  136. CHCMUi002-A

    China Children's hospital of Chongqing Medical University (CHCMU)
    Disease:

    Chronic granulomatous disease

  137. CHOCi005-A

    United States CHOC Children's (CHOC)
    Disease:

    Gm1 gangliosidosis

  138. CHOPi008-A (TMD145.T21.G1S)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Transient abnormal myelopoiesis associated with down syndrome

  139. CHOPi008-B (TMD145.E46.G1S)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Transient abnormal myelopoiesis associated with down syndrome

  140. CHOPi008-C (DS145.T21.G1)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Transient abnormal myelopoiesis associated with down syndrome

  141. CHOPi012-A (CHOPACTG2-R257C)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Megacystis-microcolon-intestinal hypoperistalsis syndrome 5

  142. CHOPe003-A (WA09, H9)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Normal (average)

  143. CHULAi001-A (GPDi001-A)

    Thailand Chulalongkorn University (CHULA)
    Disease:

    Glucose-6-phosphate dehydrogenase deficiency

  144. CIAUi002-C (UBC3 M1)

    Australia Centenary Institute of Cancer Medicine and Cell Biology (CIAU)
    Disease:

    Left bundle branch block

    Disease:

    Nonischemic cardiomyopathy

  145. CIAUi003-A (MCCIi005-A-1 and BFC4)

    Australia Centenary Institute of Cancer Medicine and Cell Biology (CIAU)
    Disease:

    Catecholaminergic polymorphic ventricular tachycardia 2

  146. CIAUi003-A-1 (BFC4-C and BFC4-CRISPR-corrected)

    Australia Centenary Institute of Cancer Medicine and Cell Biology (CIAU)
    Disease:

    Catecholaminergic polymorphic ventricular tachycardia 2

  147. CIPi001-A

    China Children’s Hospital of Capital Institute of Pediatrics (CIP)
    Disease:

    Benign familial infantile epilepsy

  148. CIPi002-A

    China Children’s Hospital of Capital Institute of Pediatrics (CIP)
  149. CMCi006-A-1 (CMC-Fb001(A4GALT-KO))

    South Korea Catholic University of Korea (CMC)
    Disease:

    Fabry disease

  150. CMFTe004-A (Man-16)

    United Kingdom Central Manchester and Manchester Children's University Hospitals NHS (CMFT)
    Disease:

    Normal (average)

  151. CMGANTi003-A (SEMD1)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    X-linked spondyloepimetaphyseal dysplasia

  152. CMGANTi004-A (SEMD2)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    X-linked spondyloepimetaphyseal dysplasia

  153. CMGANTi005-A (iPSC_MFS_FBN1_MCE-KB_C8)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Marfan syndrome

  154. CMGANTi006-A (SEDC1)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Spondyloepiphyseal dysplasia congenita

  155. CMGANTi007-A (SEDC2)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Spondyloepiphyseal dysplasia congenita

  156. CPGHi004-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Normal (average)

  157. CPGHi006-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Autosomal dominant polycystic kidney disease

  158. CPGHi007-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Normal (average)

  159. CPGHi008-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Autosomal recessive polycystic kidney disease

  160. CRICKi001-A (iFCI001)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Intellectual disability

  161. CRICKi002-A (iFCI027)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Intellectual disability

  162. CRICKi003-A (iFCI002)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Intellectual disability

  163. CRICKi004-A (iFCI008)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy with lower extremity predominant

  164. CRICKi005-A (iFCI004)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy

  165. CRICKi006-A (iFCI005)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy

  166. CRICKi007-A (iFCI009)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy with lower extremity predominant

  167. CRICKi008-A (iFCI006 and NH13-0078)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    X-linked centronuclear myopathy

  168. CRICKi009-A (iFCI012 and iFCI012 CLONE 4)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Vhl

  169. CRICKi010-A (iFCI013 and iFCI013 Clone 7)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Vhl

  170. CRICKi011-A (iFCI016)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Young-onset parkinson disease

  171. CRICKi012-A (iFCI017)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Young-onset parkinson disease

  172. CRMi003-A (NCRM-1 and NL-1)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal (average)

  173. CRTDi006-A

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 1

  174. CRTDi006-B

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 1

  175. CRTDi007-A

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 1

  176. CRTDi007-B

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 1

  177. CRTDi008-B

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 5

  178. CRTDi009-A

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 5

  179. CRTDi010-B

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 5

  180. CRTDi011-A (IDP52555 #9)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal (average)

  181. CRTDi011-B (IDP52555 #13)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal (average)

  182. CRTDi011-C (IDP52555 #36)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal (average)

  183. CRTDi011-D (IDP52555 #44)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal (average)

  184. CSSi013-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Normal (average)

  185. CSSi014-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Mucopolysaccharidosis ii

  186. CSSi015-A (FC17)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Normal (average)

  187. CSSi016-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Charcot-marie-tooth disease type 4b3

  188. CSUXHEi001-A

    China Central South University (CSUXHE)
    Disease:

    Normal (average)

  189. CSUXHEi002-A

    China Central South University (CSUXHE)
    Disease:

    Normal (average)

  190. CTEFe001-A (MUCG01)

    Czech Republic Cell and Tissue Engineering Facility (CTEF)
    Disease:

    Normal (average)

  191. CTEFe002-A (MUCG02)

    Czech Republic Cell and Tissue Engineering Facility (CTEF)
    Disease:

    Normal (average)

  192. CTEFe003-A (MUCG03)

    Czech Republic Cell and Tissue Engineering Facility (CTEF)
    Disease:

    Normal (average)

  193. CTGUi001-A (FD01 and F01)

    China China Three Gorges University (CTGU)
    Disease:

    Fabry disease

  194. WAe001-A-95 (CTU-hES-1)

    China GIBH (CTU)
    Disease:

    Microcephaly-capillary malformation syndrome

  195. CUBi001-A

    Germany Charité - Universitätsmedizin Berlin (CUB)
    Disease:

    Mirage syndrome

  196. CUIMCi005-A (BB#2 and BB9068#2)

    United States Columbia University Irving Medical Center (CUIMC)
    Disease:

    Stargardt disease

  197. DHMi004-A-1 (HOS_1460corr 127 Clone 31)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  198. DHMi004-A-2 (HOS_1460_FLAG Clone 4)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  199. DHMi004-A-3 (HOS_1460corr 127 Clone 31_FLAG Clone 18)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  200. DHMi005-A-2 (L_FLAG Clone 5)

    Germany German Heart Center Munich (DHM)
    Disease:

    Normal (average)

  201. DHMi005-A-3 (L_FLAG Clone 6)

    Germany German Heart Center Munich (DHM)
    Disease:

    Normal (average)

  202. DHMi005-A-4 (L_FLAG Clone 7)

    Germany German Heart Center Munich (DHM)
    Disease:

    Normal (average)

  203. DHMi005-A-5 (L_mut_FLAG Clone 4)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  204. DHMi005-A-6 (L_mut_FLAG Clone 14)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  205. DHMi005-A-7 (L_mut_FLAG Clone 15)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  206. DMBi001-A

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Normal (average)

  207. DMBi001-A-2

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Normal (average)

  208. DMBi003-A

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Rheumatoid arthritis

  209. DMBi004-A

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Rheumatoid arthritis

  210. DMBi010-A

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Lymphedema-distichiasis syndrome

  211. DPNJMUi001-A

    China Children's Hospital of Nanjing Medical University (DPNJMU)
    Disease:

    Combined oxidative phosphorylation deficiency 23

  212. DRICUi003-A (LC56A10005A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimer's disease

  213. DRICUi004-A (LC56A10012A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimer's disease

  214. DRICUi006-A (ADANG10496CA)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimer's disease

  215. DRICUi007-A (ADANG10605CA)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimer's disease

  216. EDi020-A (SFCi55)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (average)

  217. EDi046-A

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal (average)

  218. ESi035-A (AD]FiPSAG07645-4F-17)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsolete_alzheimer's disease

  219. ESi091-A (HLA91-MiPS4F3)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  220. ESi092-A (HLA98-MiPS4F15)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  221. ESi093-A (CD34 iPS1-Sv4F-B8)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  222. ESi094-A (Hz 1-8-3 CBiPS4 Sv4F F6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  223. ESi095-A (Hz 3-7-15 CBiPS3- Sv4F E9)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  224. ESi096-A (Hz 11-27-1 CBiPS8-Sv4F-J1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  225. ESi097-A (Hz 24-7-15 CBiPS7 Sv4F-I12)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  226. ESi098-A (Hz 30-18-3 CBiPS2-Sv4F-D10)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  227. ESi099-A (Hz 33-14-1 CBiPS6-Sv4F H6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal (average)

  228. ESi100-A (NW FiPS 10II.3-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams syndrome

  229. ESi101-A (THD FiPS A1 Ep6F-17)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Tyrosine hydroxylase deficiency

  230. ESi102-A (THD FiPS B1 Ep6F-15)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Tyrosine hydroxylase deficiency

  231. ESi103-A (OCD FiPS3-Ep6F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsessive-compulsive disorder

  232. ESi104-A (PMM2-CDG FiPS48-Sv4F-7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Pmm2-cdg

  233. ESi106-A (MD FiPS3304-Sv4F-5)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Mitochondrial disease

  234. FDCHi007-A

    China Children’s Hospital of Fudan University (FDCH)
    Disease:

    Developmental and epileptic encephalopathy 31a

  235. FDCHi008-A (JYIPS0087)

    China Children’s Hospital of Fudan University (FDCH)
    Disease:

    Chronic intestinal pseudoobstruction

  236. FDHPIi001-A

    China (WITHDRAWN) Fudan University (FDHPI)
    Disease:

    Neurodegeneration

  237. FHUSTCi001-A

    China The First Affiliated Hospital of USTC,Division of life Science and Medicine,University of Science and Technology of China (FHUSTC)
    Disease:

    Glomerulopathy

  238. FHUSTCi002-A

    China The First Affiliated Hospital of USTC,Division of life Science and Medicine,University of Science and Technology of China (FHUSTC)
    Disease:

    Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome

  239. FINCBi004-A

    Italy Fondazione IRCCS Istituto Neurologico C. Besta (FINCB)
    Disease:

    Neurodegeneration with brain iron accumulation 4

  240. FJMUNi001-A

    China Department of Neurology, Fujian Institute of Neurology, the First Affiliated Hospital, Fujian Medical University (FJMUN)
    Disease:

    Duchenne muscular dystrophy

  241. FJMUUHi001-A

    China Fujian Medical University Union Hospital (FJMUUH)
    Disease:

    Parkinson's disease 7

  242. FMCPGHi001-A (301-iPSC-normal-001A)

    China The First Medical Center of PLA General Hospital (FMCPGH)
    Disease:

    Normal (average)

  243. FMCPGHi002-A (301-iPSC-normal-002B)

    China The First Medical Center of PLA General Hospital (FMCPGH)
    Disease:

    Normal (average)

  244. FMUPDCi001-A (ADAT3c.219dupA/c.587C>T)

    China Fetal Medicine unit &Prenatal Diagnosis Center, Shanghai 1st Maternity and Infant Hospital of Tongji University (FMUPDC)
    Disease:

    Mental retardation

  245. WAe001-A-76 (H1-RNF1-/-)

    China Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
    Disease:

    Parkinson disease

  246. WAe001-A-77 (H1 RYBP-FLAG-HA KI)

    China Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
    Disease:

    Normal (average)

  247. WAe009-A-84

    China Guangxi Institute of Cardiovascular Diseases (GICD)
    Disease:

    Congenital heart disease

  248. WAe001-A-2C (SST-P2A-mCherry)

    China Guangzhou Laboratory (GL)
    Disease:

    Normal (average)

  249. GRCHJUi001-A (LYJ-iPS-C)

    China Guangzhou Red Cross Hospital of Jinan University (GRCHJU)
    Disease:

    Atrial fibrillation

  250. GWCMCi001-A (iPS-57)

    China Guangzhou Women and Children's Medical Center (GWCMC)
    Disease:

    Iga glomerulonephritis

  251. GWCMCi005-A (GWCMCi-TANC2)

    China Guangzhou Women and Children's Medical Center (GWCMC)
    Disease:

    Lennox-gastaut syndrome

  252. HADe002-A (HAD 2)

    Israel Hadassah University Hospital (HAD)
    Disease:

    Cystic fibrosis

  253. HEBHMUi008-A

    China Hebei Medical University (HEBHMU)
    Disease:

    Cerebrovascular disease

  254. HEBHMUi012-A

    China Hebei Medical University (HEBHMU)
    Disease:

    Hypertension

  255. HEBHMUi013-A

    China Hebei Medical University (HEBHMU)
    Disease:

    Alzheimer's disease

  256. HHUi003-B (A4_C1)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Maternally-inherited leigh syndrome

  257. HHUi003-C (A4_W1)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Maternally-inherited leigh syndrome

  258. HHUi006-A (11656_H)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Normal (average)

  259. HHUi006-B (11656_K)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Normal (average)

  260. HHUUKDi001-A (ISRM-UM51 and UM51-iPSC)

    Germany Heinrich-Heine-Universität Düsseldorf (HHUUKD)
    Disease:

    Normal (average)

  261. HHUUKDi009-A (TFBJ)

    Germany Heinrich-Heine-Universität Düsseldorf (HHUUKD)
    Disease:

    Normal (average)

  262. HHUUKDi011-A (AATD iPSC-1 and ISRM-AATD-iPSC-1)

    Germany Heinrich-Heine-Universität Düsseldorf (HHUUKD)
    Disease:

    Alpha-1 antitrypsin deficiency

  263. HHUUKDi012-A (AATD iPSC-2 and ISRM-AATD-iPSC-2)

    Germany Heinrich-Heine-Universität Düsseldorf (HHUUKD)
    Disease:

    Alpha-1 antitrypsin deficiency

  264. HIHCNi008-A (iPSC-CO-4)

    Germany Hertie Institute for Clinical Brain Research - Clinical Neurogenetics (HIHCN)
    Disease:

    Normal (average)

  265. HIHRSi004-A

    Germany Hertie Institute for Clinical Brain Research, AG Schüle (HIHRS)
    Disease:

    Spastic ataxia

  266. HIHRSi005-A

    Germany Hertie Institute for Clinical Brain Research, AG Schüle (HIHRS)
    Disease:

    Spastic ataxia

  267. HIHRSi006-A

    Germany Hertie Institute for Clinical Brain Research, AG Schüle (HIHRS)
    Disease:

    Spastic ataxia

  268. HMSCATi001-A

    China Stem Cell Application and Translation Laboratory (HMSCAT)
    Disease:

    Normal (average)

  269. HMSCATi003-A

    China Stem Cell Application and Translation Laboratory (HMSCAT)
    Disease:

    Parkinson disease

  270. HMSCATi004-A

    China Stem Cell Application and Translation Laboratory (HMSCAT)
    Disease:

    Young-onset parkinson disease

  271. HMSCATi005-A

    China Stem Cell Application and Translation Laboratory (HMSCAT)
    Disease:

    Alzheimer's disease

  272. HMSCATi006-A

    China Stem Cell Application and Translation Laboratory (HMSCAT)
    Disease:

    Epileptic encephalopathy

  273. HUJIi001-A (iWSM-F1)

    Israel Hebrew University of Jerusalem (HUJI)
    Disease:

    Developmental and epileptic encephalopathy, 28

  274. HUJIi002-A (iWSM-M2)

    Israel Hebrew University of Jerusalem (HUJI)
    Disease:

    Developmental and epileptic encephalopathy, 28

  275. HUJIi003-A (iWSM-S5)

    Israel Hebrew University of Jerusalem (HUJI)
    Disease:

    Developmental and epileptic encephalopathy, 28

  276. IAIi002-A (IAIi002RSTS1-34-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  277. IAIi005-A (AC52)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Normal (average)

  278. IAIi006-A (BC6)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Amyotrophic lateral sclerosis

  279. IAIi007-A (CC5)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Amyotrophic lateral sclerosis

  280. IAIi008-A (DC2)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Amyotrophic lateral sclerosis

  281. IAIi009-A (EC1)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Normal (average)

  282. IAIi010-A (Kif5A 1847 C3)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Autosomal dominant spastic paraplegia type 10

  283. IBBISTi004-A (AS-GB clone 12)

    Portugal Simão José Teixeira da Rocha (IBBIST)
    Disease:

    Angelman syndrome

  284. IBBISTi004-B (AS-GB clone 20)

    Portugal Simão José Teixeira da Rocha (IBBIST)
    Disease:

    Angelman syndrome

  285. IBBISTi004-C (AS-GB clone 22)

    Portugal Simão José Teixeira da Rocha (IBBIST)
    Disease:

    Angelman syndrome

  286. IBKMOLi002-A (CACNA1D L271H iPCs)

    Austria University of Innsbruck, Institute of Molecular Biology (IBKMOL)
    Disease:

    Autism spectrum disorder

    Disease:

    Hyperinsulinemic hypoglycemia

    Disease:

    Primary hyperaldosteronism

    Disease:

    Muscle hypotonia

  287. IBMSi027-A (IBMS-iPSC-073-01)

    Taiwan Institute of Biomedical Sciences, Academia Sinica (IBMS)
    Disease:

    Wolfram syndrome

  288. BIONi010-C-65 (BiONI010-C-O16)

    Germany Fraunhofer Institute for Biomedical Engineering IBMT (IBMT)
    Disease:

    Cystic fibrosis

  289. BIONi010-C-66 (BIONi010-C-N7)

    Germany Fraunhofer Institute for Biomedical Engineering IBMT (IBMT)
    Disease:

    Cystic fibrosis

  290. IBTCMi001-A (NDC1)

    China Institute of Basic Theory for Chinese Medicine (IBTCM)
    Disease:

    Normal (average)

  291. IBTCMi002-A (NDC2)

    China Institute of Basic Theory for Chinese Medicine (IBTCM)
    Disease:

    Normal (average)

  292. IBTCMi003-A (AD1)

    China Institute of Basic Theory for Chinese Medicine (IBTCM)
    Disease:

    Alzheimer's disease

  293. IBTCMi004-A (AD2)

    China Institute of Basic Theory for Chinese Medicine (IBTCM)
    Disease:

    Alzheimer's disease

  294. IBTCMi005-A (AD3)

    China Institute of Basic Theory for Chinese Medicine (IBTCM)
    Disease:

    Alzheimer's disease

  295. IBTCMi006-A (ACNE1)

    China Institute of Basic Theory for Chinese Medicine (IBTCM)
    Disease:

    Acne

  296. ICANi002-A-2 (SCN5A-Clone 5)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Normal (average)

  297. ICGi008-A (m55Alz-9L)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Obsolete_alzheimer's disease

  298. ICGi008-B (m55Alz-15L)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Obsolete_alzheimer's disease

  299. ICGi022-A-3 (K7-MYBPC3-N515del-1)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Healthy subject

  300. ICGi022-A-4 (K7-MYBPC3-N515del-2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Healthy subject

  301. ICGi022-A-5 (K7-MYBPC3-N515del-3)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Healthy subject

  302. ICGi033-A (77Q-17)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington disease

  303. ICGi033-B (77Q-9)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington disease

  304. ICGi033-C (77Q-20)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington disease

  305. ICGi039-A (PD31-6)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Normal (average)

  306. ICGi039-B (PD31-7)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Normal (average)

  307. ICGi039-C (PD31-15)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Normal (average)

  308. ICGi040-A (iTAF16-3)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Infertility

  309. ICGi042-A (PD12-4Lm)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  310. ICGi042-B (PD12-5Lm)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  311. ICGi042-C (PD12-6Lm)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  312. ICGi043-A (LR-21)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  313. ICGi043-B (LR-2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  314. ICGi043-C (LR-15)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  315. ICGi044-A (PD40-7)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  316. ICGi044-B (PD40-8)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  317. ICGi044-C (PD40-13)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson disease

  318. ICSSUi002-A

    China Institute for Cardiovascular Science of Soochow University (ICSSU)
    Disease:

    Aortic dissection

  319. IDIBGIi001-A (GPG1-C23)

    Spain Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)
    Disease:

    Normal (average)

  320. IDIBGIi002-A (RB20234)

    Spain Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)
    Disease:

    Brugada syndrome

  321. IDIBGIi003-A (​RB20235)

    Spain Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)
    Disease:

    Brugada syndrome

  322. IDIBGIi004-A (RB20236)

    Spain Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)
    Disease:

    Brugada syndrome

  323. IDIBGIi005-A (RB20237)

    Spain Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)
    Disease:

    Normal (average)

  324. IGGi002-A

    Italy IRCCS Istituto Giannina Gaslini (IGG)
    Disease:

    Cystic fibrosis

  325. IIMCBi003-A (K-Pic1)

    Poland International Institute of Molecular and Cell Biology in Warsaw (IIMCB)
    Disease:

    Normal (average)

  326. IIMCBi004-A (PM-H1)

    Poland International Institute of Molecular and Cell Biology in Warsaw (IIMCB)
  327. IIMCBi005-A (EM-K3)

    Poland International Institute of Molecular and Cell Biology in Warsaw (IIMCB)
  328. IIMCBi006-A (M-T1)

    Poland International Institute of Molecular and Cell Biology in Warsaw (IIMCB)
    Disease:

    Huntington's disease

  329. IMBAi001-A (SCCF-176J clone#1)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  330. IMBAi001-B (SCCF-176J clone#2)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  331. IMBAi002-A (SCCF-177J clone#8)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  332. IMBAi002-B (SCCF-177J clone#4)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  333. IMBAi002-C (SCCF-177J clone#6)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  334. IMBAi003-A (SCCF-178J clone#5)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  335. IMBAi003-B (SCCF-178J clone#6)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  336. IMBAi009-A (SCCF-179J clone#13)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  337. IMBAi009-B (SCCF-179J clone#15)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  338. IMBAi009-C (SCCF-179J clone#18)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  339. IMBAi010-A (SCCF-2298J clone#1)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  340. IMBAi010-B (SCCF-2298J clone#2)

    Austria Institute of Molecular Biotechnology (IMBA)
    Disease:

    Normal (average)

  341. INNDSUi001-A (186-Nml-F-24)

    China Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University (INNDSU)
    Disease:

    Normal (average)

  342. INNDSUi002-A (21-013)

    China Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University (INNDSU)
    Disease:

    Multiple acyl-coa dehydrogenase deficiency

  343. INNDSUi003-A

    China Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University (INNDSU)
    Disease:

    Becker muscular dystrophy

  344. IOBi001-A (F49B7 and 01F49i-N-B7)

    Switzerland Institute of Molecular and Clinical Ophthalmology Basel (IOB) (IOB)
    Disease:

    Normal (average)

  345. IRFMNi001-A (iPS clone IV)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Normal (average)

  346. IRFMNi001-B-2 (CIone M CIITAKO-B2MKO)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Normal (average)

  347. IRFMNi002-A (PRM#14)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Focal segmental glomerulosclerosis

  348. IRFMNi002-B (PRM#18)

    Italy IRCCS - Istituto di Ricerche Farmacologiche Mario Negri (IRFMN)
    Disease:

    Focal segmental glomerulosclerosis

  349. IRMBi002-A (AD-APP hiPSC)

    France Institute for Regenerative Medecine and Biotherapy (IRMB)
    Disease:

    Obsolete_alzheimer's disease

  350. SNUe003-A-4 (T-mC-KI-SE-3)

    South Korea Institute of Reproductive Medicine and Population, Medical Research Cener, (IRMP)
    Disease:

    Normal (average)

  351. ISCRMi001-A (3-0062 and DSP Leu462fs)

    United States University of Washington Institute for Stem Cell and Regenerative Medicine (ISCRM)
    Disease:

    Inherited arrhythmogenic cardiomyopathy

  352. ISFi003-A (D2)

    Germany Institute for Stem Cell Research (ISF)
    Disease:

    Van maldergem syndrome 1

  353. ISFi004-A (F1)

    Germany Institute for Stem Cell Research (ISF)
    Disease:

    Van maldergem syndrome 1

  354. ISTEMi001-A

    France Institut from Stem cell Therapy and Exploration of Monogenic diseases (ISTEM)
    Disease:

    Glycogen storage disease type iii

  355. ISTEMi002-A

    France Institut from Stem cell Therapy and Exploration of Monogenic diseases (ISTEM)
    Disease:

    Glycogen storage disease type iii

  356. ISTEMi003-A

    France Institut from Stem cell Therapy and Exploration of Monogenic diseases (ISTEM)
    Disease:

    Glycogen storage disease type iii

  357. ITXi001-A (hERG CT Cl9)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  358. ITXi001-A-1 (GPR146KO Cl2)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  359. ITXi002-A (IRX5-Wt and H166Wt C09)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  360. ITXi002-A-1 (CRISPR-2 IRX5 F12 Het and IRX5-Het)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  361. ITXi002-A-2 (CRISPR-2 IRX5 D8 KO and IRX5-KO)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  362. ITXi002-A-3 (IRX5-KI and CRISPR-3 IRX5 F6 KI)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  363. ITXi003-A (MS368)

    France l’institut du thorax (ITX)
    Disease:

    Long qt syndrome

  364. ITXi004-A (MS381)

    France l’institut du thorax (ITX)
    Disease:

    Long qt syndrome

  365. ITXi005-A (MS573)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  366. ITXi006-A (WT8288)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  367. ITXi007-A (202CT)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  368. ITXi008-A (SD378M)

    France l’institut du thorax (ITX)
    Disease:

    Normal (average)

  369. ITXi009-A (CPVT068)

    France l’institut du thorax (ITX)
    Disease:

    Catecholaminergic polymorphic ventricular tachycardia

  370. ITXi010-A (CPVT249)

    France l’institut du thorax (ITX)
    Disease:

    Catecholaminergic polymorphic ventricular tachycardia

  371. ITXi011-A (CPVT033)

    France l’institut du thorax (ITX)
    Disease:

    Catecholaminergic polymorphic ventricular tachycardia

  372. IUFi002-A

    Germany IUF – Leibniz Research Institute for Environmental Medicine (IUF)
    Disease:

    Leigh syndrome

  373. JNCSRe002-A-1 (BJNhem20-OCIAD2-CRISPR-33)

    India Jawaharlal Nehru Centre for Advanced Scientific Research (JNCSR)
    Disease:

    Normal (average)

  374. JNCSRe002-A-2 (BJNhem20-OCIAD2-CRISPR-40)

    India Jawaharlal Nehru Centre for Advanced Scientific Research (JNCSR)
    Disease:

    Normal (average)

  375. JNCSRe002-A-3 (BJNhem20 OCIAD2-OV)

    India Jawaharlal Nehru Centre for Advanced Scientific Research (JNCSR)
    Disease:

    Normal (average)

  376. JTUi004-A

    China Sixth People's Hospital, Shanghai Jiao Tong University (JTU)
    Disease:

    Otosclerosis

  377. JUCGRMi001-A (VPS35A4)

    Japan Center for Genomic and Regenerative Medicine, Juntendo University (JUCGRM)
    Disease:

    Parkinson disease

  378. JUCGRMi001-B (VPS35A5)

    Japan Center for Genomic and Regenerative Medicine, Juntendo University (JUCGRM)
    Disease:

    Parkinson disease

  379. JUCGRMi001-C (VPS35A8)

    Japan Center for Genomic and Regenerative Medicine, Juntendo University (JUCGRM)
    Disease:

    Parkinson disease

  380. JUCTCi018-A

    Jordan the University of Jordan / Cell Therapy center (JUCTC)
    Disease:

    Charcot-marie-tooth disease

  381. JUCTCi019-A

    Jordan the University of Jordan / Cell Therapy center (JUCTC)
    Disease:

    Charcot-marie-tooth disease type 2

  382. WAe001-A-78 (H1X10 and H1X-10)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  383. WAe001-A-82 (H1X-59 and H1X59)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  384. WAe001-A-83 (H1.0-29 and H1.029)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  385. WAe001-A-84 (H1.117 and H1.1-17)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  386. WAe001-A-85 (H1.0102 and H1.0-102)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  387. WAe001-A-86 (H1.139 and H1.1-39)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  388. WAe001-A-87 (H1.213 and H1.2-13)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  389. WAe001-A-88 (H1.2-124 and H1.2124)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  390. WAe001-A-89 (H1.3-64 and H1.364)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  391. WAe001-A-90 (H1.3-191 and H1.3191)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  392. WAe001-A-91 (H1.4-126 and H1.4126)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  393. WAe001-A-92 (H1.4-143 and H1.4143)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  394. WAe001-A-93 (H1.5-23 and H1.523)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  395. WAe001-A-94 (H1.528 and H1.5-28)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  396. WAe001-A-96 (H1X-10/H1.0-31 and H1X10/H1.031)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  397. WAe001-A-97 (H1X-59/H1.0-19 and H1X59/H1019)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  398. WAe001-A-98 (H1X-10/H1.1-1 and H1X10/H1.11)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  399. WAe001-A-99 (H1X-59/H1.1-13 and H1X59/H1.113)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  400. WAe001-A-A (H1X-10/H1.2-20)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  401. WAe001-A-B (H1X-59/H1.2-6)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  402. WAe001-A-C (H1X-10/H1.3-62)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  403. WAe001-A-D (H1X-59/H1.3-68)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  404. WAe001-A-E (H1X-10/H1.4-4)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  405. WAe001-A-F (H1X-59/H1.4-5)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  406. WAe001-A-G (H1X-10/H1.5-1)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  407. WAe001-A-H (H1X-59/H1.5-33)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  408. WAe001-A-I (H1.0-29/H1.1-13)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  409. WAe001-A-J (H1.0-102/H1.1-34)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  410. WAe001-A-K (H1.0-29/H1.2-31)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  411. WAe001-A-L (H1.0-102/H1.2-6)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  412. WAe001-A-M (H1.0-29/H1.3-22)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  413. WAe001-A-N (H1.0-102/H1.3-90)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  414. WAe001-A-O (H1.0-29/H1.4-14)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  415. WAe001-A-P (H1.0-102/H1.4-19)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  416. WAe001-A-Q (H1.0-29/H1.5-6)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  417. WAe001-A-R (H1.0-102/H1.5-44)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  418. WAe001-A-S (H1.1-17/H1.2-11)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  419. WAe001-A-T (H1.1-39/H1.2-9)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  420. WAe001-A-U (H1.1-17/H1.4-18)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  421. WAe001-A-V (H1.1-39/H1.4-17)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  422. WAe001-A-W (H1.1-17/H1.5-14)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  423. WAe001-A-X (H1.1-39/H1.5-26)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  424. WAe001-A-Y (H1.2-13/H1.3-35)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  425. WAe001-A-Z (H1.2-124/H1.3-23)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  426. WAe001-A-1A (H1.2-13/H1.4-69)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  427. WAe001-A-1B (H1.2-124/H1.4-84)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  428. WAe001-A-1C (H1.2-13/H1.5-23)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  429. WAe001-A-1D (H1.2-124/H1.5-70)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  430. WAe001-A-1E (H1.3-64/H1.1-37)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  431. WAe001-A-1F (H1.3-191/H1.1-9)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  432. WAe001-A-1G (H1.3-64/H1.4-15)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  433. WAe001-A-1H (H1.3-191/H1.4-11)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  434. WAe001-A-1I (H1.3-64/H1.5-38)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  435. WAe001-A-1J (H1.3-191/H1.5-2)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  436. WAe001-A-1K (H1.4-126/H1.5-73)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  437. WAe001-A-1L (H1.4-143/H1.5-36)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal (average)

  438. KEIOi005-A (KAD-0001 and EK-0076)

    Japan Keio University (KEIO)
    Disease:

    Alzheimer's disease

  439. KEIUi002-A (KOMENT-A)

    Japan Keio University (KEIU)
    Disease:

    Normal (average)

  440. KEIUi003-A (KOMENT-B)

    Japan Keio University (KEIU)
    Disease:

    Normal (average)

  441. WAe009-A-99 (dCas9-p300 H9 21)

    South Korea Korea Institute of Toxicology (KIT)
    Disease:

    Normal (average)

  442. KLRMMEi001-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Retinitis pigmentosa

  443. KLRMMEi003-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Usher syndrome

  444. KMUGMCi003-A (KMUGMCi003ERCC2 and KN610)

    Japan Kanazawa Medical University (KMUGMC)
    Disease:

    Trichothiodystrophy 1, photosensitive

  445. KMUGMCi004-A (KMUGMCi004APC and KN615)

    Japan Kanazawa Medical University (KMUGMC)
    Disease:

    Familial adenomatous polyposis

  446. KMUGMCi005-A (KMUGMCi005TMC8 and KN627)

    Japan Kanazawa Medical University (KMUGMC)
    Disease:

    Epidermodysplasia verruciformis

  447. KMUGMCi006-A (TS271 #12 WT)

    Japan Kanazawa Medical University (KMUGMC)
    Disease:

    Tuberous sclerosis

  448. KMUGMCi007-A (KMUGMCi007PEPD and KN649)

    Japan Kanazawa Medical University (KMUGMC)
    Disease:

    Prolidase deficiency

  449. KRIBBi005-A (CB-iPS-C7)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    Normal (average)

  450. KRIBBi009-A (KRIBB-BC15)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    Normal (average)

  451. WAe009-A-95 (hTRF1-KO #3)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    Normal (average)

  452. WAe009-A-96 (hTRF1-KO #6)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    None

  453. WAe009-A-97 (hTRF1-KO #9)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    None

  454. KSCBi012-A (NU01-EiPS07)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (average)

  455. KSCBi017-A (PB01-EiPS21)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal (average)

  456. KUCFRi005-A

    South Korea Korea University Cell Function Regulation Lab (KUCFR)
    Disease:

    Normal (average)

  457. KUCFRi005-A-1

    South Korea Korea University Cell Function Regulation Lab (KUCFR)
    Disease:

    African swine fever virus

  458. KUIMSe001-A (KhES-1)

    Japan Kyoto University (KUIMS)
    Disease:

    Normal (average)

  459. SIGi001-A-21 (SIGi001-AAVS1-FRT)

    Belgium KU Leuven (KUL)
    Disease:

    Normal (average)

  460. SIGi001-A-22 (SIGi001-ICAM1-GFP)

    Belgium KU Leuven (KUL)
    Disease:

    Normal (average)

  461. SIGi001-A-23 (SIGi001-HC3x)

    Belgium KU Leuven (KUL)
    Disease:

    Normal (average)

  462. SIGi001-A-24 (SIGi001-HC3x-ICAM1-GFP)

    Belgium KU Leuven (KUL)
    Disease:

    Normal (average)

  463. KULi003-A

    Belgium KU Leuven (KUL)
    Disease:

    Normal (average)

  464. KUMi004-A

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Chronic lymphocytic leukemia

  465. KUMi005-A

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Multiple myeloma

  466. KUMi006-A

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Multiple myeloma

  467. LBi001-A (PH-BL-001 Clone 4 and iLB-268bfs4)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  468. LBi001-B (iLB-268bfs9 and PH-BL-001 Clone 9)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  469. LBi002-A (PH-BL-002 Clone 2 and iLB-272bfs2)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  470. LBi002-B (PH-BL-002 Clone 9 and iLB-272bfs9)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  471. LBi003-A (iLB-273bms57 and PH-BL-003 Clone 57)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  472. LBi003-B (PH-BL-003 Clone 61 and iLB-273bms61)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  473. LBi004-A (PH-BL-204 Clone 210 and iLB-278bfs210)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  474. LBi004-B (PH-BL-204 Clone 211 and iLB-278bfs211)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  475. LBi005-A (iLB-293bms257 and PH-BL-411 Clone 257)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  476. LBi005-B (iLB-293bms258 and PH-BL-411 Clone 258)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  477. LBi006-A (PH-BL-102 Clone 16 and iLB-269bms16)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  478. LBi006-B (iLB-269bms8 and PH-BL-102 Clone 8)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  479. LBi007-A (iLB-285bfs98 and PH-BL-406 Clone 98)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  480. LBi007-B (iLB-285bfs99 and PH-BL-406 Clone 99)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  481. LBi008-A (PH-BL-407 Clone 128 and iLB-289bms128)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  482. LBi008-B (iLB-289bms145 and PH-BL-407 Clone 145)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  483. LBi009-A (PH-BL-405 Clone 174 and iLB-284bms174)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  484. LBi009-B (iLB-284bms179 and PH-BL-405 Clone 179)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  485. LBi010-A (PH-BL-403 Clone 275 and iLB-282bfs275)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  486. LBi010-B (iLB-282bfs283 and PH-BL-403 Clone 283)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  487. LBi011-A (PH-BL-004 Clone 14 and iLB-274bfs14)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  488. LBi011-B (PH-BL-004 Clone 17 and iLB-274bfs17)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  489. LBi012-A (iLB-292bms74 and PH-BL-410 Clone 74)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  490. LBi012-B (PH-BL-410 Clone 80 and iLB-292bms80)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  491. LBi013-A (PH-BL-304 Clone 117 and iLB-279bfs117)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  492. LBi014-A (iLB-281bfs191 and PH-BL-402 Clone 191)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  493. LBi014-B (PH-BL-402 Clone 192 and iLB-281bfs192)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  494. LBi015-A (iLB-277bms227 and PH-BL-303 Clone 227)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  495. LBi015-B (iLB-277bms234 and PH-BL-303 Clone 234)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  496. LBi016-A (PH-BL-414 Clone 10 and iLB-296bfs10)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  497. LBi016-B (PH-BL-414 Clone 16 and iLB-296bfs16)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  498. LBi017-A (PH-BL-401 Clone 22 and iLB-280bfs22)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  499. LBi017-B (PH-BL-401 Clone 36 and iLB-280bfs36)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  500. LBi018-A (PH-BL-409 Clone 43 and iLB-291bfs43)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  501. LBi018-B (PH-BL-409 Clone 45 and iLB-291bfs45)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  502. LBi019-A (PH-BL-901 Clone 154 and iLB-275bms154)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  503. LBi019-B (iLB-275bms162 and PH-BL-901 Clone 162)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  504. LBi020-A (iLB-294bms22 and PH-BL-412 Clone 238)

    Germany Life & Brain GmbH (LB)
    Disease:

    Alzheimer disease

  505. LCPHi001-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Obsolete_parkinson's disease

  506. LCPHi002-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Parkinson disease

  507. LCPHi003-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Parkinson disease

  508. LCSBi002-B (ND40066-clone 7 and ND40066-PINK1/PARK6-ILE368ASN-clone 7)

    United States Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  509. LCSBi002-C (ND40066-clone 8 and ND40066-PINK1/PARK6-ILE368ASN-clone 8)

    United States Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  510. LCSBi004-A (ND29369-clone 1 and ND29369-PARKIN/PRKN/PARK2-R275W-clone 1)

    United States Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  511. LCSBi004-B (ND29369-PARKIN/PRKN/PARK2-R275W-clone 4, ND29369-clone 4, ND29369-4 and LCSBi004-B)

    United States Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  512. LCSBi008-A (delP and DJ-1-delP)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  513. LCSBi008-A-1 (delP GC13 and DJ-1-delP GC13)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  514. LCSBi009-A (RHOT1_R272Q_clone1_PD)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  515. LCSBi009-A-1 (RHOT1_R272Q_clone18_IsogenicControl)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  516. LCSBi010-A (RHOT1_R450C_clone5_PD)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  517. LCSBi010-A-1 (RHOT1_R450C_clone6_IsogenicControl)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  518. LCSBi010-A-2 (RHOT1_R450C_clone10_IsogenicControl)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  519. LCSBi011-A (RHOT1_T351A_clone1_PD)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  520. LCSBi011-A-1 (RHOT1_T351A_clone25.2_IsogenicControl)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  521. LCSBi012-A (RHOT1_T610A_clone6_PD)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  522. LCSBi012-A-1 (RHOT1_T610A_clone62.19.37_IsogenicControl)

    Luxembourg Luxembourg Centre for Systems Biomedicine (LCSB)
    Disease:

    Parkinson disease

  523. LSCTRi006-A (LSCTR-LiPSC-4 and i4)

    South Korea Laboratory of Stem Cells and Tissue Regeneration (LSCTR)
    Disease:

    Normal (average)

  524. LSCTRi007-A (LSCTR-LiPSC-5 and i5)

    South Korea Laboratory of Stem Cells and Tissue Regeneration (LSCTR)
    Disease:

    Normal (average)

  525. LUMCi002-A (113-6 and LUMC0113iATAX06)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia type 1

  526. CRMi003-A-3 (Proliving and GMNN-mScarletI Reporter)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  527. LUMCi004-A-1 (LU99_AAVS1-bxb-v2)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  528. LUMCi004-A-2 (LU99_CLYBL-bxb-v2)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  529. LUMCi048-A (LUMCi048CTRL-A, 48CTRL-A and 48CTRL-3)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  530. LUMCi048-B (48CTRL-B, LUMCi048CTRL-B and 48CTRL-6)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  531. LUMCi048-C (LUMCi048CTRL-C, 48CTRL-C and 48CTRL-8)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  532. LUMCi049-A (LUMCi049SCA3-A, 49SCA3-A and 49SCA3-1)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  533. LUMCi049-B (LUMCi049SCA3-B, 49SCA3-B and 49SCA3-2)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  534. LUMCi049-C (LUMCi049SCA3-C, 49SCA3-C and 49SCA3-4)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal (average)

  535. LUMCi051-A

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia type 7

  536. LUMCi051-B

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia type 7

  537. LUMCi052-A

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia 7

  538. LUMCi052-B

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia 7

  539. LUMCi052-C

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Spinocerebellar ataxia 7

  540. LVPEIi001-A (hiPSC-F2-3F1 and LVIP01-NC-F2-1)

    India L.V. Prasad Eye Institute (LVPEI)
    Disease:

    Normal (average)

  541. LZUSHi002-A

    China Lanzhou University Second Hospital (LZUSH)
    Disease:

    Madd

  542. MCRIi004-A (PB004)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Normal (average)

  543. MCRIi005-A (PB005)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Normal (average)

  544. MCRIi006-A (PB006)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Normal (average)

  545. MCRIi010-A (PB010)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Normal (average)

  546. MCRIi025-A (CANVAS1-2)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

  547. MCRIi025-B (CANVAS1-2 Het GC)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

  548. MCRIi026-A (CANVAS3-2)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

  549. MCRIi026-B (CANVAS3-2 Het GC)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

  550. MCRIi027-A (CANVAS4-6)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

  551. MCRIi027-B (CANVAS4-6 Het GC)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

  552. HMGUi001-A-22 (NCS1-KO Clone 19)

    Germany Max Delbrück Center Berlin Buch (MDC)
    Disease:

    Normal (average)

  553. MDCi007-A (8993-A12)

    Germany Max Delbrück Center Berlin Buch (MDC)
    Disease:

    Leigh disease

  554. MDCi008-A (8993-B12)

    Germany Max Delbrück Center Berlin Buch (MDC)
    Disease:

    Leigh disease

  555. MDCi009-A (8993-C11)

    Germany Max Delbrück Center Berlin Buch (MDC)
    Disease:

    Leigh disease

  556. MDCi010-A (8993-D7)

    Germany Max Delbrück Center Berlin Buch (MDC)
    Disease:

    Leigh disease

  557. MLUi007-J

    Germany Medical Faculty of the Martin Luther University Halle-Wittenberg (MLU)
    Disease:

    Alzheimer disease

  558. MMCi002-A (MMC-iPSC-002-A)

    Taiwan Mackay Medical College (MMC)
    Disease:

    Hearing loss

  559. MNZTASi001-A (MS_0004, 2125-2 and TOB-02125)

    Australia Menzies Institute for Medical Research (MNZTAS)
    Disease:

    Primary progressive multiple sclerosis

  560. MNZTASi002-A (MS_0001)

    Australia Menzies Institute for Medical Research (MNZTAS)
    Disease:

    Relapsing-remitting multiple sclerosis

  561. MNZTASi003-A (MS_0002)

    Australia Menzies Institute for Medical Research (MNZTAS)
    Disease:

    Relapsing-remitting multiple sclerosis

  562. MNZTASi004-A (MS_0003)

    Australia Menzies Institute for Medical Research (MNZTAS)
    Disease:

    Relapsing-remitting multiple sclerosis

  563. MNZTASi005-A (MS_0006)

    Australia Menzies Institute for Medical Research (MNZTAS)
    Disease:

    Relapsing-remitting multiple sclerosis

  564. MPIPi057-A (UL1)

    Germany Max Planck Institute of Psychiatry (MPIP)
    Disease:

    Progressive myoclonic epilepsy type 1

  565. MPIPi058-A (UL4)

    Germany Max Planck Institute of Psychiatry (MPIP)
    Disease:

    Progressive myoclonic epilepsy type 1

  566. MRIi001-A-1 (C6-AAVS1-iCasRx)

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Normal (average)

  567. MRIi003-A-7 (HK-AAVS1-iCasRx)

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Normal (average)

  568. MRIi003-A-8 (HK-AAVS1-CAG-eGFP-homo)

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Normal (average)

  569. MRIi003-A-9 (HK-AAVS1-CAG-FRT-stop-FRT-mKate2-hetero)

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Normal (average)

  570. MRIi005-A

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Long qt syndrome 1

  571. MRIi027-A (DMD 01)

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Duchenne muscular dystrophy

  572. WAe009-A-1I (H9::GFP cyto-reporter line)

    United States Memorial Sloan Kettering Cancer Center (MSK)
    Disease:

    Normal (average)

  573. WAe009-A-1J (H9::mcherry cyto-reporter line)

    United States Memorial Sloan Kettering Cancer Center (MSK)
    Disease:

    Normal (average)

  574. MUi026-A (MU012.C4)

    Thailand Mahidol University (MU)
    Disease:

    Autosomal dominant polycystic kidney disease

  575. MUi027-A (MU013.C2)

    Thailand Mahidol University (MU)
  576. MUi031-A (Gaucher iPSC3)

    Thailand Mahidol University (MU)
    Disease:

    Gaucher disease type 3

  577. MUi032-A

    Thailand Mahidol University (MU)
    Disease:

    Choroideremia

  578. MUi034-A (homoHbCS iPSC and MU018)

    Thailand Mahidol University (MU)
    Disease:

    Alpha thalassemia spectrum

  579. MUBi002-A (CF 001)

    Poland Medical University of Bialystok (MUB)
    Disease:

    Cystic fibrosis

  580. MUBi005-A (iPSC_COPD)

    Poland Medical University of Bialystok (MUB)
    Disease:

    Chronic obstructive pulmonary disease

  581. MUNIi018-A (HUVEC-iPSC)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Normal (average)

  582. MUNIi018-B (HUVEC-hiPSC-macroH2A1.1)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Normal (average)

  583. MUNIi018-C (HUVEC-hiPSC-macroH2A1.2)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Normal (average)

  584. MUSIi009-A (HDF-iPSCs)

    Thailand Faculty of Medicine Siriraj Hospital (MUSI)
    Disease:

    Normal (average)

  585. MUSIi016-A (TyO)

    Thailand Faculty of Medicine Siriraj Hospital (MUSI)
    Disease:

    Normal (average)

  586. MUSIi019-A (SLC4A1-21-C1)

    Thailand Faculty of Medicine Siriraj Hospital (MUSI)
    Disease:

    Distal renal tubular acidosis

  587. NCBSi003-A (Park14-R741Q-2022)

    India National Center for Biological Sciences (NCBS)
    Disease:

    Autosomal recessive parkinson disease 14

  588. NCBSi004-A (Park14-control-2022)

    India National Center for Biological Sciences (NCBS)
    Disease:

    Normal (average)

  589. WAe009-A-91

    China National Center for Cardiovascular Diseases & Fuwai Hospital (NCCDFW)
    Disease:

    Barth syndrome

  590. WAe009-A-92

    China National Center for Cardiovascular Diseases & Fuwai Hospital (NCCDFW)
    Disease:

    Normal (average)

  591. WAe009-A-93 (NIS-EGFP-Fluc H9)

    China National Center for Cardiovascular Diseases & Fuwai Hospital (NCCDFW)
    Disease:

    Normal (average)

  592. NCHi001-A (LCL-iPSC4802)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Congenital heart disease

  593. NCHi003-A (NCH005)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Pulmonary valve atresia with intact ventricular septum

  594. NCHi004-A (NCH140)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Down syndrome

  595. NCHi006-A (NCH023)

    United States Nationwide Children's Hospital (NCH)
  596. NCHi009-A (NCH78)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Hypoplastic left heart syndrome

  597. NFHHMUi001-A

    China Department of Neurosurgery of The First Affiliated Hospital of Harbin Medical University (NFHHMU)
    Disease:

    Cerebral cavernous malformation

  598. NHGRIi001-A (iPSC-1 and FISAL04_Sia80)

    United States National Human Genome Research Institute (NHGRI)
  599. NHGRIi002-A (iPSC-2 and CDG.1121_Sia74)

    United States National Human Genome Research Institute (NHGRI)
  600. NIHTVBi016-A (HT876D)

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
  601. NIHTVBi017-A (HT939A)

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
  602. NIHTVBi018-A (HT940B)

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
  603. NIHTVBi019-A (HT852)

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Leukodystrophy

  604. NIHTVBi019-A-1 (HT852-DC)

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Leukodystrophy

  605. NIHTVBi020-A (HT853)

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Normal (average)

  606. NIHTVBi021-A (HT854)

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Normal (average)

  607. NIHTVBi022-A (HT964)

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Leukodystrophy

  608. NIHTVBi024-A

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
  609. NIHTVBi025-A

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Sting-associated vasculopathy with onset in infancy

  610. NIHTVBi026-A

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Sting-associated vasculopathy with onset in infancy

  611. NIHTVBi027-A

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Sting-associated vasculopathy with onset in infancy

  612. NIHTVBi028-A

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Lyn gene mutation

  613. NIMHi004-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal (average)

  614. NIMHi005-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal (average)

  615. NIMHi006-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal (average)

  616. NIMHi009-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal (average)

  617. NIMHi010-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal (average)

  618. NIMHi013-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Epilepsy

  619. NIMHi014-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Epilepsy

  620. TMOi001-A-5 (DISC1 Ex2 D5)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Normal (average)

  621. TMOi001-A-6 (DISC1 Ex2 C4)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Normal (average)

  622. NMIi011-A (B1.4)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  623. NMIi011-B (B1.6)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  624. NMIi011-C (B1.7)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  625. NMIi011-D (B1.10)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  626. NMIi012-A (DG1)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  627. NMIi012-B (DG2)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  628. NMIi012-D (DG4)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  629. NMIi012-E (DG5)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  630. NSi003-A (NSi-DS)

    India Stem Cell and Neurobiology Lab (NS)
    Disease:

    Down syndrome

  631. NSi003-B (NSi-isoEu)

    India Stem Cell and Neurobiology Lab (NS)
    Disease:

    Down syndrome

  632. NTUHi002-A

    Taiwan National Taiwan University Hospital (NTUH)
    Disease:

    Aceruloplasminemia

  633. NUIGi059-A (EP2001 C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Epileptic encephalopathy

  634. NUIGi059-B (EP2001 C5)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Epileptic encephalopathy

  635. NUIGi059-C (EP2001 C8)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Epileptic encephalopathy

  636. NUIGi060-A (EP2C001 C1)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (average)

  637. NUIGi060-B (EP2C001 C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (average)

  638. NUIGi060-C (EP2C001 C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (average)

  639. NUIGi063-A (EP2003 C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Kcnq2-related epileptic encephalopathy

  640. NUIGi063-B (EP2003 C3)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Kcnq2-related epileptic encephalopathy

  641. NUIGi063-C (EP2003 C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Kcnq2-related epileptic encephalopathy

  642. NUIGi064-A (EP2C003 C2)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (average)

  643. NUIGi064-B (EP2C003 C3)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (average)

  644. NUIGi064-C (EP2C003 C4)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Normal (average)

  645. ORIONi002-A (iALS-2)

    Slovakia Biomedical center Martin, Jessenius Faculty of Medicine in Martin, COMENIUS UNIVERSITY IN BRATISLAVA (ORION)
    Disease:

    Sporadic amyotrophic lateral sclerosis

  646. PCIi034-A (PC138)

    France PHENOCELL (PCI)
    Disease:

    Aicardi-goutieres syndrome

  647. PFIZi013-A (RCi215 and RCFB59 C9)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Amyotrophic lateral sclerosis

  648. PGNMi001-A (AG08C5)

    France Institut NeuroMyoGene - Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM) (PGNM)
    Disease:

    Normal (average)

  649. PMUi002-A-2 (UCB144-CT2-C DOCK2KO clone 20 and Cornelius DOCK2KO clone 20)

    Austria Paracelsus Medical University (PMU)
    Disease:

    Severe combined immunodeficiency

  650. PMUi002-A-3 (Cornelius DOCK2KO clone 22 and UCB144-CT2-C DOCK2KO clone 22)

    Austria Paracelsus Medical University (PMU)
    Disease:

    Severe combined immunodeficiency

  651. PNUSCRi001-A (GBA PD iPSC7)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Parkinson disease

  652. PNUSCRi002-A (GBA PD iPSC9)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Parkinson disease

  653. PUFHi004-A (TMEM163 c.227T>C p.(Leu76Pro) iPSC)

    China Peking University First Hospital (PUFH)
    Disease:

    Leukodystrophy

  654. PUMCi002-A (AF-iPSCs and C1)

    China Peking Union Medical College (PUMC)
    Disease:

    Normal (average)

  655. PUMCHi019-A

    China Peking Union Medical College Hospital (PUMCH)
    Disease:

    Autosomal dominant optic atrophy plus syndrome

  656. QBRIi014-A (NDD01 and hiPSC_11080401_c1)

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Autism spectrum disorder

  657. QBRIi015-A (NDD04 and hiPSC_11080404_c1)

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Autism spectrum disorder

  658. QBRIi016-A (NDD05 and hiPSC_11080405_c1)

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Autism spectrum disorder

  659. QBRIi017-A (CtrlM and hiPSC_11080402_c1)

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Normal (average)

  660. QBRIi018-A (hiPSC_11080403_c1 and CtrlF)

    Qatar Qatar Biomedical Research Institute (QBRI)
    Disease:

    Normal (average)

  661. RCi007-A (FB70c1 and RCi170)

    United Kingdom Roslin Cells (RC)
    Disease:

    Facioscapulohumeral dystrophy

  662. RCi009-A (Rci201 and FB73c6)

    United Kingdom Roslin Cells (RC)
    Disease:

    Facioscapulohumeral dystrophy

  663. RCMGi002-A (P7L2)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  664. RCMGi004-A (P6L2)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  665. RCMGi004-B (P6L8)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  666. RCMGi005-A (P5L1)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  667. RCMGi005-B (P5L5)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  668. RCMGi008-A (P9L1)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  669. RCNSi003-A (2GMB7)

    Hungary RCNS-Institute of Molecular Life Sciences (RCNS)
    Disease:

    Normal (average)

  670. RCPCMi009-A (IPSRG4S and UEF-3B)

    Finland Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Normal (average)

  671. RCPCMi009-A-1 (IPSRG4S-206)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    X-linked intellectual disability, nascimento type

  672. RMCGENi005-A

    Netherlands Radboudumc - Department of Human Genetics (RMCGEN)
    Disease:

    Stargardt disease

  673. RMCGENi005-A-1

    Netherlands Radboudumc - Department of Human Genetics (RMCGEN)
    Disease:

    Stargardt disease

  674. SCTCi017-A-1

    Netherlands Radboudumc - Department of Human Genetics (RMCGEN)
    Disease:

    Stargardt disease

  675. SCTCi018-A-1

    Netherlands Radboudumc - Department of Human Genetics (RMCGEN)
    Disease:

    Stargardt disease

  676. SCIKFi001-A (D3-iR-2)

    Indonesia Stem Cell and Cancer Institute, PT. Kalbe Farma Tbk. (SCIKF)
    Disease:

    Normal (average)

  677. SCMCi001-A

    China Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine (SCMC)
    Disease:

    Normal (average)

  678. SCTi003-A

    United States STEMCELL Technologies Inc. (SCT)
    Disease:

    Normal (average)

  679. SCTCi017-A (IPS15-00006)

    Netherlands Radboudumc Stem Cell Technology Center (SCTC)
    Disease:

    Stargardt disease

  680. SCTCi018-A (IPS15-00007)

    Netherlands Radboudumc Stem Cell Technology Center (SCTC)
    Disease:

    Stargardt disease

  681. SCVIi030-A

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Inherited arrhythmogenic cardiomyopathy

  682. SCVIi031-A

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Inherited arrhythmogenic cardiomyopathy

  683. SCVIi036-A (SCVI248)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Hypertrophic cardiomyopathy

  684. SCVIi037-A (SCVI672)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Hypertrophic cardiomyopathy

  685. SCVIi049-A (SCVI104)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Dilated cardiomyopathy

  686. SCVIi050-A (SCVI2486)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Dilated cardiomyopathy

  687. SCVIi051-A (477)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Normal (average)

  688. SCVIi053-A (2021)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Normal (average)

  689. SCVIi055-A (SCVI868 and SCVI-868)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Normal (average)

  690. SCVIi056-A (SCVI956 and SCVI-956)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Normal (average)

  691. SCVIi057-A (SCVI-975 and SCVI975)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Normal (average)

  692. SCVIi059-A (SCVIi2413)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Dilated cardiomyopathy

  693. SCVIi060-A (SCVi2506)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Dilated cardiomyopathy

  694. SCVIi061-A (SCVI2149C1)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Long qt syndrome

  695. SCVIi062-A (SCVI2150c1)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Long qt syndrome

  696. SCVIi066-A (SCVI2047)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Transthyretin amyloid cardiomyopathy

  697. SCVIi067-A (SCVI2742)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Transthyretin amyloid cardiomyopathy

  698. SCVIi073-A (SCVIi574C2)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Dilated cardiomyopathy

  699. SCVIi074-A (SCVIi599C1)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Hypertrophic cardiomyopathy

  700. SDASi001-A

    China Qilu University of Technology(Shandong Academy of Sciences) (SDAS)
    Disease:

    Schimke immuno-osseous dysplasia

  701. SDCHi008-A (CX2)

    China Children's Hospital Affiliated to Shandong University (SDCH)
    Disease:

    Epilepsy

  702. SDPHi002-A

    China Shandong Provincial Hospital Affiliated to Shandong First Medical University (SDPH)
    Disease:

    Lung cancer

  703. SDPHi003-A

    China Shandong Provincial Hospital Affiliated to Shandong First Medical University (SDPH)
    Disease:

    Normal (average)

  704. SDPHi004-A

    China Shandong Provincial Hospital Affiliated to Shandong First Medical University (SDPH)
    Disease:

    Normal (average)

  705. SDPHi005-A

    China Shandong Provincial Hospital Affiliated to Shandong First Medical University (SDPH)
    Disease:

    Normal (average)

  706. SDPHi006-A

    China Shandong Provincial Hospital Affiliated to Shandong First Medical University (SDPH)
    Disease:

    Normal (average)

  707. SDQLCHi067-A

    China Children’s Hospital affiliated to Shandong University (SDQLCH)
    Disease:

    Subcortical band heterotopia

  708. SDUCHi001-A

    China Children’s Hospital Affiliated to Shandong University (SDUCH)
    Disease:

    Normal (average)

  709. SDZFYi001-A

    China Shandong Academy of Occupational Health and Occupational Medicine (SDZFY)
    Disease:

    Normal (average)

  710. SFMUi001-A

    China Shandong First Medical University (SFMU)
    Disease:

    Usher syndrome type 2

  711. SFPHi001-A

    China Shanghai Fifth People’s Hospital (SFPH)
    Disease:

    Hereditary antithrombin deficiency

  712. SHCDNi006-A (SHCDN006)

    China Shanghai Children's Hospital (SHCDN)
    Disease:

    Epilepsy

  713. SHCDNi007-A

    China Shanghai Children's Hospital (SHCDN)
    Disease:

    Pyruvate carboxylase deficiency

  714. SHCDNRi001-A (IPS-51)

    China Shanghai Children's Hospital, Department of Nephrology and Rheumatology (SHCDNR)
    Disease:

    Alport syndrome

  715. SHETi003-A

    China Department of Cardiology, Shanghai Children's Hospital (SHET)
    Disease:

    Catecholaminergic polymorphic ventricular tachycardia

  716. SHETi004-A

    China Department of Cardiology, Shanghai Children's Hospital (SHET)
    Disease:

    Left bundle branch block artifact

  717. SHUPLi002-A (iPS-26)

    China Shanghai University of Political Science and Law (SHUPL)
    Disease:

    Normal (average)

  718. SIAISi011-A (NZM)

    China Shanghai Institute for Advanced Immunochemical Studies (SIAIS) (SIAIS)
    Disease:

    Normal (average)

  719. SIAISi016-A

    China Shanghai Institute for Advanced Immunochemical Studies (SIAIS) (SIAIS)
    Disease:

    Alzheimer's disease

  720. SIAISi019-A

    China Shanghai Institute for Advanced Immunochemical Studies (SIAIS) (SIAIS)
    Disease:

    Normal (average)

  721. SIAISi020-A

    China Shanghai Institute for Advanced Immunochemical Studies (SIAIS) (SIAIS)
    Disease:

    Mild cognitive impairment

  722. SIAISi021-A

    China Shanghai Institute for Advanced Immunochemical Studies (SIAIS) (SIAIS)
    Disease:

    Obsolete_alzheimer's disease

  723. SIGi001-A-12 (iPSC0028 - BiAllelic MAPT_Ex10+16T/Clone 1F5-D12 and SAMEA104237570)

    United States Sigma-Aldrich (SIG)
    Disease:

    Frontotemporal dementia

  724. SIPDi001-A (Li-Campeau syndrome)

    China Shaanxi Institute of Pediatric Diseases (SIPD)
    Disease:

    Li-campeau syndrome

  725. SJTUi003-A

    China Shanghai Jiao Tong University School of Medicine (SJTU)
    Disease:

    Alzheimer's disease

  726. SJTUGHi001-A

    China Shanghai General Hospital (SJTUGH)
    Disease:

    Retinitis pigmentosa

  727. SKLRMi001-A

    China State Key Laboratory of Reproductive Medicine, Nanjing Medical University (SKLRM)
    Disease:

    Androgen insensitivity syndrome

  728. SKLRMe005-A

    China State Key Laboratory of Reproductive Medicine, Nanjing Medical University (SKLRM)
  729. SMBCi010-A

    China Shandong Medicinal Biotechnology Center (SMBC)
    Disease:

    Multiple osteochondromas

  730. SMBCi011-A

    China Shandong Medicinal Biotechnology Center (SMBC)
    Disease:

    Prader-willi syndrome

  731. SMBCi013-A (WD-iPSC)

    China Shandong Medicinal Biotechnology Center (SMBC)
    Disease:

    Hepatolenticular degeneration

  732. SMBCi014-A

    China Shandong Medicinal Biotechnology Center (SMBC)
    Disease:

    Osteogenesis imperfecta

  733. SMBCi018-A

    China Shandong Medicinal Biotechnology Center (SMBC)
    Disease:

    Clubfoot

  734. SMUDHe001-A

    China Southern Medical University (SMUDH)
    Disease:

    Normal (average)

  735. WAe009-A-82

    China Southern Medical University (SMUDH)
    Disease:

    Primary cutaneous amyloidosis

  736. WAe009-A-1A

    China Southern Medical University (SMUDH)
    Disease:

    Normal (average)